BIOFISH HOLDING |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.29 NOK | 0.00% |
|
+1.98% | -7.86% |
| Mar. 22 | BioFish Holding AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Mar. 22 | BioFish Holding AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 193.5 | 80.4 | 131.2 | 131.2 | - |
| Enterprise Value (EV) 1 | 193.5 | 80.4 | 123.7 | 103.2 | 90.24 |
| P/E ratio | - | - | -9.92 x | -21.5 x | 10.8 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 10.6 x | 3.97 x | 2.59 x | 1.87 x | 1.02 x |
| EV / Revenue | 10.6 x | 3.97 x | 2.59 x | 1.47 x | 0.7 x |
| EV / EBITDA | -28.6 x | - | -31.7 x | 9.39 x | 2.05 x |
| EV / FCF | - | - | -2.87 x | -3.97 x | 6.94 x |
| FCF Yield | - | - | -34.8% | -25.2% | 14.4% |
| Price to Book | - | - | 0.56 x | 0.81 x | 0.72 x |
| Nbr of stocks (in thousands) | 13,400 | 13,400 | 101,735 | 101,735 | - |
| Reference price 2 | 14.44 | 6.000 | 1.290 | 1.290 | 1.290 |
| Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 18.33 | 20.24 | 47.68 | 70 | 129 |
| EBITDA 1 | -6.755 | - | -3.906 | 11 | 44 |
| EBIT 1 | -7.155 | - | -10.16 | -1 | 32 |
| Operating Margin | -39.04% | - | -21.3% | -1.43% | 24.81% |
| Earnings before Tax (EBT) 1 | - | - | -12.32 | -6 | 29 |
| Net income 1 | - | -14.89 | -12.01 | -7 | 22 |
| Net margin | - | -73.56% | -25.19% | -10% | 17.05% |
| EPS 2 | - | - | -0.1300 | -0.0600 | 0.1200 |
| Free Cash Flow 1 | - | - | -61 | -26 | 13 |
| FCF margin | - | - | -127.08% | -37.14% | 10.08% |
| FCF Conversion (EBITDA) | - | - | - | - | 29.55% |
| FCF Conversion (Net income) | - | - | - | - | 59.09% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
1NOK in Million2NOK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 S1 | 2022 Q1 | 2022 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.84 | 7.681 | 1.98 | 1.98 | 27.58 | - | 16 | 3.2 | 27 | 27 |
| EBITDA 1 | - | - | -6.32 | -6.32 | - | -8.517 | 2 | -5 | 7 | 7 |
| EBIT 1 | - | - | -6.92 | -6.92 | - | -11.52 | -1 | -8 | 4 | 4 |
| Operating Margin | - | - | -349.49% | -349.49% | - | - | -6.25% | -250% | 14.81% | 14.81% |
| Earnings before Tax (EBT) 1 | - | - | -7.03 | - | - | -13.11 | -2 | -9 | 3 | 3 |
| Net income 1 | - | - | -7.03 | - | 8.083 | -12.8 | -2 | -9 | 2 | 2 |
| Net margin | - | - | -355.05% | - | 29.31% | - | -12.5% | -281.25% | 7.41% | 7.41% |
| EPS 2 | - | - | - | - | - | -0.1200 | -0.0200 | -0.0900 | 0.0100 | 0.0100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 9/30/21 | 9/30/21 | 9/30/22 | 9/30/22 | 12/14/23 | 3/22/24 | - | - | - | - |
1NOK in Million2NOK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 44 | - | - |
| Net Cash position 1 | - | - | - | 28 | 41 |
| Leverage (Debt/EBITDA) | - | - | -22 x | - | - |
| Free Cash Flow 1 | - | - | -61 | -26 | 13 |
| ROE (net income / shareholders' equity) | - | - | - | - | 9.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 2.300 | 1.600 | 1.800 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 43 | 12 | 12 |
| Capex / Sales | - | - | 89.58% | 17.14% | 9.3% |
| Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
1NOK in Million2NOK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.29
NOK
Average target price
2
NOK
Spread / Average Target
+55.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.86% | 12.1M | |
| +17.11% | 3.4B | |
| 0.00% | 1.07B | |
| +8.78% | 768M | |
| -.--% | 484M | |
| -14.71% | 410M | |
| +27.75% | 403M | |
| -4.21% | 394M | |
| -6.90% | 385M | |
| +16.13% | 352M |
- Stock Market
- Equities
- BFISH Stock
- Financials BioFish Holding
